Standard Biotools (LAB) Enterprise Value (2010 - 2026)

Standard Biotools (LAB) has 17 years of Enterprise Value data on file, last reported at -$455.2 million in Q1 2026.

• On a quarterly basis, Enterprise Value fell 74.63% year-over-year to -$455.2 million in Q1 2026; TTM through Mar 2026 was -$455.2 million, a 74.63% decrease from a year earlier, with the FY2025 full-year figure at -$187.6 million, up 36.41% from the prior year.
• Enterprise Value for Q1 2026 stood at -$455.2 million, down from -$187.6 million in the prior quarter.
• Over the last five years, Enterprise Value for LAB reached as high as -$31.0 million in Q1 2022 and fell as low as -$463.6 million in Q1 2024.
• Historically, Enterprise Value has averaged -$235.1 million across 5 years, with a median of -$194.9 million in 2025.
• Across the five-year window, Enterprise Value plunged 20788.48% in 2022 and jumped 46.98% in 2025, its largest moves.
• Year by year, Enterprise Value stood at -$166.8 million in 2022, then soared by 30.64% to -$115.7 million in 2023, then plunged by 154.96% to -$295.0 million in 2024, then jumped by 36.41% to -$187.6 million in 2025, then tumbled by 142.66% to -$455.2 million in 2026.
• Per Business Quant data, the three most recent Enterprise Value figures were -$455.2 million in Q1 2026, -$187.6 million in Q4 2025, and -$194.9 million in Q3 2025.